{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:48:37Z","timestamp":1783619317166,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhejiang General Research Project on Medical Health and Science Technology Plan","award":["No.2021KY951"],"award-info":[{"award-number":["No.2021KY951"]}]},{"name":"Hangzhou Medical Health Science and Technology Project","award":["No.A20200280"],"award-info":[{"award-number":["No.A20200280"]}]},{"name":"Hangzhou Medical Health Science and Technology Project","award":["No.A20200788"],"award-info":[{"award-number":["No.A20200788"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-024-20273-7","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T02:02:57Z","timestamp":1729130577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012\u20132022 in Hangzhou, China: implication for public health strategies"],"prefix":"10.1186","volume":"24","author":[{"given":"Qingchun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiuFeng","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"20273_CR1","volume-title":"Globally Tuberculosis Report 2022","author":"WHO","year":"2022","unstructured":"WHO. Globally tuberculosis report 2022. Geneva: World Health Organization; 2022."},{"key":"20273_CR2","doi-asserted-by":"publisher","first-page":"101825","DOI":"10.1016\/j.eclinm.2023.101825","volume":"56","author":"P Kumwichar","year":"2023","unstructured":"Kumwichar P, Chongsuvivatwong V. COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases. EClinicalMedicine. 2023;56:101825.","journal-title":"EClinicalMedicine"},{"key":"20273_CR3","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhao Y. Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management. BMJ Case Rep. 2018;11:bcr2018225794.","DOI":"10.1136\/bcr-2018-225794"},{"key":"20273_CR4","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","volume":"18","author":"S Tiberi","year":"2018","unstructured":"Tiberi S, Plessis Nd, Walzl G, Vjecha MJ, Rao M, Ntoumi F, et al. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018;18:e183\u201398.","journal-title":"Lancet Infect Dis"},{"key":"20273_CR5","doi-asserted-by":"crossref","unstructured":"Salvatore PP, Kendall EA, Seabrook D, Brown J, Durham GH, Dowdy DW. Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam. Sci Rep. 2019;9(1).","DOI":"10.1038\/s41598-019-54561-9"},{"issue":"6","key":"20273_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.4103\/jfmpc.jfmpc_1723_22","volume":"12","author":"GS Kumar","year":"2023","unstructured":"Kumar GS, Sameena P, Karthik V, Ghanate N. Prospective study on outcome of MDR-TB using the shorter regimen during COVID-19 pandemic. J Family Med Prim Care. 2023;12(6):1087\u201391.","journal-title":"J Family Med Prim Care"},{"issue":"4","key":"20273_CR7","doi-asserted-by":"publisher","first-page":"e047023","DOI":"10.1136\/bmjopen-2020-047023","volume":"11","author":"W Jiang","year":"2021","unstructured":"Jiang W, Peng Y, Wang X, Elbers C, Tang S, Huang F, et al. Policy changes and the screening, diagnosis and treatment of drug-resistant tuberculosis patients from 2015 to 2018 in Zhejiang Province, China: a retrospective cohort study. BMJ Open. 2021;11(4):e047023.","journal-title":"BMJ Open"},{"issue":"30","key":"20273_CR8","doi-asserted-by":"publisher","first-page":"e21296","DOI":"10.1097\/MD.0000000000021296","volume":"99","author":"Q Li","year":"2020","unstructured":"Li Q, Shi CX, Lu M, Wu L, Wu Y, Wang M, et al. Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015. Med (Baltim). 2020;99(30):e21296.","journal-title":"Med (Baltim)"},{"key":"20273_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13756-018-0348-7","volume":"7","author":"Q Li","year":"2018","unstructured":"Li Q, Zhao G, Wu L, Lu M, Liu W, Wu Y, et al. Prevalence and patterns of drug resistance among pulmonary tuberculosis patients in Hangzhou, China. Antimicrob Resist Infect Control. 2018;7:61.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"20273_CR10","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.3346\/jkms.2023.38.e33","volume":"38","author":"H Choi","year":"2023","unstructured":"Choi H, Mok J, Kang YA, Jeong D, Kang HY, Kim HJ, et al. Nationwide treatment outcomes of patients with multidrug\/rifampin-resistant tuberculosis in Korea, 2011\u20132017: a retrospective cohort study (Korean TB-POST). J Korean Med Sci. 2023;38(5):e33.","journal-title":"J Korean Med Sci"},{"key":"20273_CR11","unstructured":"Hangzhou Municipal Bureau of Statistics. Hangzhou statistical yearbook 2013. 2013 [ http:\/\/tjj.hangzhou.gov.cn\/art\/2013\/10\/23\/art_1229453592_3819406.html"},{"key":"20273_CR12","unstructured":"Hangzhou Municipal Bureau of Statistics. Hangzhou statistical yearbook 2023. 2023 [ http:\/\/tjj.hangzhou.gov.cn\/art\/2023\/12\/4\/art_1229453592_4222689.html"},{"key":"20273_CR13","doi-asserted-by":"crossref","unstructured":"Flores-Valdez MA, Kupz A, Subbian S. Recent developments in mycobacteria-based live attenuated vaccine candidates for tuberculosis. Biomedicines. 2022;10(11).","DOI":"10.3390\/biomedicines10112749"},{"issue":"9","key":"20273_CR14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(19)30263-2","volume":"7","author":"K Dheda","year":"2019","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, et al. The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. Lancet Respir Med. 2019;7(9):820\u20136.","journal-title":"Lancet Respir Med"},{"key":"20273_CR15","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","volume":"130","author":"E Vanino","year":"2023","unstructured":"Vanino E, Granozzi B, Akkerman OW, Munoz-Torrico M, Palmieri F, Seaworth B, et al. Update of drug-resistant tuberculosis treatment guidelines: a turning point. Int J Infect Dis. 2023;130:S12\u20135.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"20273_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/amiajnl-2013-002001","volume":"21","author":"F Huang","year":"2014","unstructured":"Huang F, Cheng S, Du X, Chen W, Scano F, Falzon D, et al. Electronic recording and reporting system for tuberculosis in China: experience and opportunities. J Am Med Inf Assoc. 2014;21(5):938\u201341.","journal-title":"J Am Med Inf Assoc"},{"key":"20273_CR17","volume-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020","author":"WH Organization","year":"2021","unstructured":"Organization WH. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020. Geneva: World Health Organization; 2021."},{"key":"20273_CR18","doi-asserted-by":"crossref","unstructured":"Ding P, Li X, Jia Z, Lu Z. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis. BMC Infect Dis. 2017;17(57).","DOI":"10.1186\/s12879-016-2151-5"},{"key":"20273_CR19","first-page":"1","volume":"2020","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang M, Wang J, Chen S, Wu B, Zhou L, et al. Longitudinal analysis of prevalence and risk factors of rifampicin-resistant tuberculosis in Zhejiang, China. Biomed Res Int. 2020;2020:1\u20138.","journal-title":"Biomed Res Int"},{"key":"20273_CR20","doi-asserted-by":"crossref","unstructured":"Liao S, Cai C, Huo FM, Wu JN, Kong CC, Huang HR et al. Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre. 2017;21(9):990-995.","DOI":"10.5588\/ijtld.17.0086"},{"key":"20273_CR21","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/IDR.S335329","volume":"14","author":"J Lecai","year":"2021","unstructured":"Lecai J, Mijiti P, Chuangyue H, Mingzhen L, Qian G, Weiguo T, et al. Predictors and trends of MDR\/RR-TB in Shenzhen China: a retrospective 2012\u20132020 period analysis. Infect Drug Resist. 2021;14:4481\u201391.","journal-title":"Infect Drug Resist"},{"key":"20273_CR22","doi-asserted-by":"crossref","unstructured":"Lopez MG, Dogba JB, Torres-Puente M, Goig GA, Moreno-Molina M, Villamayor LM et al. Tuberculosis in Liberia: high multidrug-resistance burden, transmission and diversity modelled by multiple importation events. Microb Genom. 2020;6(1).","DOI":"10.1099\/mgen.0.000325"},{"key":"20273_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40794-018-0065-5","volume":"4","author":"T Girum","year":"2018","unstructured":"Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4:5.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"20273_CR24","doi-asserted-by":"publisher","first-page":"2923549","DOI":"10.1155\/2019\/2923549","volume":"2019","author":"K Mehari","year":"2019","unstructured":"Mehari K, Asmelash T, Hailekiros H, Wubayehu T, Godefay H, Araya T, et al. Prevalence and factors associated with multidrug-resistant tuberculosis (MDR-TB) amongPresumptive MDR-TB patients in Tigray Region, Northern Ethiopia. Can J Infect Dis Med Microbiol. 2019;2019:2923549.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"20273_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/s12889-017-4779-5","volume":"17","author":"V Goyal","year":"2017","unstructured":"Goyal V, Kadam V, Narang P, Singh V. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health. 2017;17:817.","journal-title":"BMC Public Health"},{"key":"20273_CR26","doi-asserted-by":"crossref","unstructured":"Migliori GB, Thong PM, Alffenaar J-W, Denholm J, Tadolini M, Alyaquobi F et al. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J. 2021;58(5).","DOI":"10.1183\/13993003.01786-2021"},{"key":"20273_CR27","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.ijid.2023.02.025","volume":"130","author":"J Nalunjogi","year":"2023","unstructured":"Nalunjogi J, Mucching-Toscano S, Sibomana JP, Centis R, D\u2019Ambrosio L, Alffenaar J-W, et al. Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study. Int J Infect Dis. 2023;130:S25\u20139.","journal-title":"Int J Infect Dis"},{"key":"20273_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/JMDH.S341130","volume":"15","author":"GJ Caren","year":"2022","unstructured":"Caren GJ, Iskandar D, Pitaloka DAE, Abdulah R, Suwantika AA. COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia. J Multidisciplinary Healthc. 2022;15:175\u201383.","journal-title":"J Multidisciplinary Healthc"},{"issue":"10","key":"20273_CR29","first-page":"791","volume":"33","author":"QJ Jia","year":"2020","unstructured":"Jia QJ, Zeng MC, Li QC, Wu YF, Lu M, Ai LY, et al. Recent transmission analysis of 66 MDR-TB strains using the 15-locus MIRU-VNTR Method. Biomedical Environ Sci. 2020;33(10):791\u20135.","journal-title":"Biomedical Environ Sci"},{"issue":"4","key":"20273_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S2213-2600(21)00020-5","volume":"9","author":"KV Driessche","year":"2021","unstructured":"Driessche KV, Mahlobo PZ, Venter R, Caldwell J, Jennings K, Diacon AH, et al. Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response? Lancet Respiratory Med. 2021;9(4):340\u20132.","journal-title":"Lancet Respiratory Med"},{"issue":"12","key":"20273_CR31","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.5588\/ijtld.18.0125","volume":"22","author":"E Ge","year":"2018","unstructured":"Ge E, Li D, Luo M, Tsui KWS, Waye MMY, Shen X, et al. Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status. Int J Tuberc Lung Dis. 2018;22(12):1462\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"20273_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jmii.2022.08.014","volume":"56","author":"HE Jeong","year":"2023","unstructured":"Jeong HE, Bea S, Kim JH, Jang SH, Son H, Shin J-Y. Socioeconomic disparities and multidrug-resistant tuberculosis in South Korea: focus on immigrants and income levels. J Microbiol Immunol Infect. 2023;56(2):424\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"20273_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12879-019-4189-7","volume":"19","author":"O Oliveira","year":"2019","unstructured":"Oliveira O, Gaio R, Carvalho C, Correia-Neves M, Duarte R, Rito T. A nationwide study of multidrug-resistant tuberculosis in Portugal 2014\u20132017 using epidemiological and molecular clustering analyses. BMC Infect Dis. 2019;19(1):567.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"20273_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.7883\/yoken.JJID.2021.643","volume":"75","author":"Y Kobayashi","year":"2022","unstructured":"Kobayashi Y, Tateishi A, Hiroi Y, Minakuchi T, Mukouyama H, Ota M, et al. Multidrug-resistant tuberculosis outbreak among immigrants in Tokyo, Japan, 2019\u20132021. Jpn J Infect Dis. 2022;75(5):527\u20139.","journal-title":"Jpn J Infect Dis"},{"issue":"3","key":"20273_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cmi.2016.09.009","volume":"23","author":"S Hargreaves","year":"2017","unstructured":"Hargreaves S, Lonnroth K, Nellums LB, Olaru ID, Nathavitharana RR, Norredam M, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2017;23(3):141\u20136.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-20273-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20273-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T02:03:37Z","timestamp":1729130617000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-20273-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["20273"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-20273-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4081954\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Hangzhou Center for Disease Control and Prevention. Due to the use of de-identified information in this study, the ethics committee of the Hangzhou Center for Disease Control and Prevention waived the need for obtaining informed consent from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2859"}}